{"id":"W2624955713","doi":"10.1007/s00192-017-3377-5","title":"A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)","year":2017,"lang":"en","type":"article","venue":"International Urogynecology Journal","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Sherbrooke; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma Global Development; Astellas Pharma","keywords":"Tolerability; Tolterodine; Mirabegron; Medicine; Overactive bladder; Crossover study; Adverse effect; Urology; Placebo; Clinical endpoint; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001219702,0.0002847662,0.0007601365,0.000301484,0.0003926745,0.0003283172,0.0002558776,0.00006397767,0.0002642478],"category_scores_gemma":[0.0006187692,0.0001995989,0.00005714979,0.00006088086,0.0002918538,0.0005504862,0.0004478115,0.0008008983,0.000008568532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002773027,"about_ca_system_score_gemma":0.0001420238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000226512,"about_ca_topic_score_gemma":0.0004450521,"domain_scores_codex":[0.9971237,0.0004474547,0.0006488713,0.0006219968,0.0007707719,0.0003872117],"domain_scores_gemma":[0.9977661,0.0003436284,0.0003362455,0.0003244901,0.0009354174,0.0002941148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2709793,0.003968192,0.7164143,0.000005779049,0.0008382681,0.0001157595,0.004914782,0.00001117108,0.000008018659,0.000003291491,0.00001107972,0.002729991],"study_design_scores_gemma":[0.3323138,0.006070384,0.6605685,0.00003222487,0.0001417444,0.00003283651,0.0005607062,0.000051274,0.0000193062,0.00006127066,0.00002339886,0.0001245416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992323,0.00003640083,0.0000170902,0.0008057308,0.0002673197,0.005984416,0.00002531673,0.000009460322,0.0005312652],"genre_scores_gemma":[0.9991366,0.00001234079,0.0002256739,0.00009262482,0.00008703303,0.0002927629,0.000008773154,0.00002263876,0.000121558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06133448,"threshold_uncertainty_score":0.8139408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04833139589838813,"score_gpt":0.3769485257264626,"score_spread":0.3286171298280745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}